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Development of a biomimetic enzyme-linked immunosorbent 
assay based on a molecularly imprinted polymer for the detection 
of cortisol in human saliva  
Giulia Spano, Simone Cavalera, Fabio Di Nardo, Cristina Giovannoli, Laura Anfossi and Claudio 
Baggiani* 
Development of reliable molecularly imprinted sorbent assays is ensured by in-depth knowledge of the binding between the 
tracer, conventionally based on a template analogue conjugated to an enzyme, and the imprinted polymer used as a 
recognition element. To this aim, the binding properties of a cortisol-3-(O-carboxymethyl)oxime-horseradish peroxidase 
conjugate to cortisol-imprinted microparticles previously adsorbed on the bottom of microplates were assessed. The effect 
of different blocking agents as well as of different percentages of Tween 20 in the working buffer were investigated in order 
to minimise the non-specific binding of the enzyme tracer to the adsorbed imprinted microparticles. The capability of the 
enzyme tracer to bind the imprinted solid phase and to compete with free cortisol was assessed by measuring the apparent 
equilibrium dissociation constant, KD (39.7±13.5 pmol L-1) and the apparent binding site concentration, Bmax (21.7±4.3 nmol 
L-1), whereas IC50 value for cortisol competition curve was found to be 5.32±1.15 ng mL-1. Moreover, binding selectivity 
measured for several cortisol-related steroids confirmed the experimental results previously published for cortisol-
imprinted polymers. A competitive assay for the determination of cortisol in human saliva was developed with a limit of 
detection of 1.02 ng mL-1, providing quantitative results comparable to a commercial ELISA.
Introduction 
The antibody-based sorbent assay (immunoassay) is one of the 
most popular target-focused analytical methods, and in its 
countless formats it has encountered widespread applications. 
Molecular imprinting technology has shown a growing ability to 
prepare artificial molecular recognition systems, with binding 
properties similar to those of natural antibodies. Consequently, 
many investigators are confident that molecularly imprinted 
polymers (MIPs) could be used as artificial receptors instead of 
natural antibodies in the so-called “Molecularly Imprinted 
Sorbent Assay” (MISA).1-3 At the present, its feasibility and its 
potential efficacy have been demonstrated in several studies.4-
5 
Nevertheless, if compared to other applications in the field 
of MIP technology, MISA can be considered at the stage of 
development, since several relevant issues still have to be 
solved.6 Among these, one of the most important concerns the 
compatibility of MIPs with enzyme tracers in ELISA-like assay 
formats. In fact, unlike antibody binding sites that are easily 
accessible through the antigen induced fit, MIPs show narrow 
porosity. Moreover, their binding sites are characterized by 
structural stiffness which may potentially lead to steric 
hindrance phenomena for the enzyme tracer itself. As a 
consequence of that, binding kinetics might be slow and 
unfavourable for assay development. Moreover, MIPs often 
show moderately hydrophobic surfaces, prone to the 
irreversible adsorption of biomacromolecules like enzymes, 
thus increasing the analytical noise. Although several 
approaches have been proposed to overcome these 
shortcomings through surface imprinting or post-imprinting 
chemical modifications of polymers,7-10 the direct use of bulk 
polymers can still considered appealing for its semplicty and 
ease of preparation. Therefore, additional insights in the 
binding behaviour of template-enzyme conjugates towards bulk 
MIPs are foundamental to plan further experimental efforts for 
the development of a robust and reliable MISA.    
Since cortisol represents a typical target in competitive-
based applications of imprinted polymers,11-13 in this paper, we 
studied the binding of a conjugate between cortisol-3-(O-
carboxymethyl)oxime and horseradish peroxidase (F-3-CMO-
HRP) to cortisol-imprinted particles adsorbed on the bottom of 
microplates taken as a model system. The adsorption of F-3-
CMO-HRP on the adsorbed imprinted nanoparticles was 
investigated by studying the effect of different experimental 
conditions, with the goal of minimising the non-specific binding 
and optimising the competition between the enzyme tracer and 
free cortisol. The system was eventually used to measure free 
cortisol in spiked samples of human saliva,  as salivary cortisol 
levels are considered one of the most reliable marker of 
physiological stress conditions in human subjects.14 Thus, the 
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development of affordable competitive assays is of particular 
analytical relevance.15  
Introduction 
Materials and methods 
All organic solvents and reagents were of analytical grade. 
Acrylamide, arabic gum (AG), bovine serum albumin (BSA), 
casein (CAS), corticosterone, cortisol, cortisol-3-(O-
carboxymethyl)oxime (F-3-CMO), cortisone, N,N’-
diisopropylcarbodiimide, 2,2-dimethoxy-2-
phenylacetophenone (DMPA), ethylene glycol dimethacrylate 
(EDMA), horseradish peroxidase (EC 1.11.1.7, type VI-A) (HRP), 
hydroxypropylcellulose (HPC, mw 80KD), N-
hydroxysuccinimide, polyvinylalcohol (PVA, mw 90-100KD), 
polyvinylpyrrolidone (PVP, mw 40KD), prednisolone, 
prednisone, progesterone and N.N’-tetramethylbenzidine 
dihydrochloride were purchased from Sigma (Milano, Italy). 
Acetic acid, glycerol, hydrogen peroxide, Tween 20 and all 
organic solvents and salts for buffers were purchased from VWR 
International (Milano, Italy). 
Polymerization inhibitor in EDMA was removed by clean-up 
on activated alumina column. Steroid stock solutions were 
prepared by dissolving 20.0 mg of substance in 4.00 mL of 
acetonitrile and stored in the dark at −20◦C until use. 
 
Synthesis of cortisol-imprinted polymer 
The imprinted polymer was prepared according to a method 
previously reported in literature,16 with minor modifications. In 
a 5-mL thick wall borosilicate glass vial a solution with 
template:functional monomer:cross-linker molar ratio of 1:3:27 
was prepared by dissolving 50.0 mg of cortisol in 2.5 mL of 
anhydrous chloroform. Then, 98 mg of acrylamide, 2.34 mL of 
EDMA and 5 mg of DMPA were added. The solution was 
sonicated in an ultrasonic bath for 10 min, sealed, and the 
mixture was photopolymerised at 4°C for 30 h by using a 200 W 
medium-pressure Hg lamp. The bulk polymer obtained were 
broken with a steel spatula, grounded in a mechanical mortar 
and mechanically wet-sieved to 15–38 m. Then, the template 
was extracted by slurry packing the polymer in a 250x4 mm 
HPLC column and exhaustively washed with acetic acid–
methanol 1:9 (v/v) till no template was detectable at 256 nm. 
To obtain micron-sized particulate, the wet polymer 
recovered from the column was ball-milled for 8 h (60 Hz) at 
intervals of 20 min, sieved through a 10m sieve and 
repeatedly suspended in methanol for 15 min to separate the 
larger particles by sedimentation. Finally, the suspension was 
evaporated and the resulting particulate dried at 60°C 
overnight. A non-imprinted polymer (NIP) was prepared in the 
same experimantal conditions by omitting the template. 
 
Preparation of the enzyme tracer 
The cortisol-3-CMO-HRP conjugate was prepared according 
to a method previously reported in literature,17 with minor 
modifications. Equimolar amounts of F-3-CMO, N,N’-
diisopropylcarbodiimide and N-hydroxysuccinimide were mixed 
under vigorous stirring in dry cold 1,4-dioxane (about 5 
mL/mmol of steroid). The ice-cooled mixture was left to react 
for 1 h. Then, the mixture was added dropwise and under 
continuous stirring to a 10 mg mL-1 solution of HRP (molar ratio 
F-3-CMO:HRP 4:1) in 0.13 mol L-1 sodium hydrogencarbonate 
buffer pH 8.3 and left to react for 1 h at room temperature. 
The raw conjugate was purified by low pressure gel filtration 
on a 10x180 mm Sephadex G-25 column (eluent: 20 mmol L-1 
phosphate buffer, 0.15 mol L-1 NaCl, pH 7.4, PBS). The collected 
enzyme tracer was diluted 3+1 v/v with glycerol and stored at 
4°C in the dark. The enzyme tracer concentration and its 
substitution degree (i.e. mean molar ratio of cortisol to HRP) 
were determined through by HPLC by comparing peak area 
measured at different wavelengths. Chromatographic runs 
were performed on a 250x4.6 mm Hema-Sec Bio 300 column 
(Alltech, Milano, Italy) eluting with PBS (flow rate 0.25 mL min-
1, UV-Vis detection at 402 and 254 nm) showing to be 1.05 mg 
mL-1 and 1.1, respectively.18 The specific activity of the purified 
enzyme tracer was measured according to literature.19 The 
cortisol-3-CMO-HRP solution was diluted to 0.025, 0.05, 0.1, 
0.25, 0.5 and 1 ng mL-1 with PBS. Then, 100 L of each diluted 
tracer solution were dispensed into the wells of uncoated 
microplates and the colorimetric detection was carried out. The 
enzyme tracer specific activity was calculated by the slope of 
the plot absorbance vs. enzyme concentration and it represents 
the absorbance of the enzyme tracer per concentration unit in 
the experimental conditions of colorimetric detection. 
 
Colorimetric detection 
Aliquots (200 L) of 1+1 v/v chromogen–substrate mixture 
(0.02% m/v N.N’-tetramethylbenzidine dihydrochloride–
0.005% v/v hydrogen peroxide in 75 mmol L-1 citrate buffer, pH 
5) were dispensed into each well and incubated in the dark for 
30 min at 37°C. The colour development was blocked by the 
addition of 100 L of 1 mol L-1 sulphuric acid, and the 
absorbance was read at 450 nm on a microplate reader 
(Multiskan FC, ThermoFisher Scientific, Milan, Italy). When 
necessary, the resulting binding curves were fitted by using 
SigmaPlot 12 (Systat Software Inc., Richmond, CA, USA). Non-
linear least square fitting was applied to the averaged 
experimental data and weighted (1/z) Pearson VII limit 
minimization was chosen as minimisation method. 
 
Coating of microtitration plates  
A weighted amount of microparticles (2 or 20 mg mL-1) was 
suspended in ultrapure water containing a proper amount 
(0.4% or 4% w/v, with the exception of PVA used at 0.1 or 1% 
w/v because of its limited solubility in water) of blocking agent, 
namely PVA, HPC, AG, BSA, CAS or PVP, and sonicated for 15 
min. Then, 200 L of homogenous suspension were dispensed 
into the wells of polystyrene microplates (ThermoFisher 
Scientific, Milano, Italy) and dried overnight at 55°C. Coated 
microplates were stored at 4 °C until use. 
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The binding of the enzyme tracer to the coated particulates 
was measured by dispensing into each well 200 L of cortisol-3-
CMO-HRP conjugate diluted to 50 ng mL-1 with PBS, incubating 
overnight at room temperature and washing three times with 
phosphate buffer before colorimetric detection. 
 
Effect of the surface active agent 
Measurements were performed on microplates coated with 2 
mg mL-1 of non-imprinted particulate (blocking agent: PVA 1% 
w/v). The enzyme tracer was diluted to 25, 50, 75, 100, 125 and 
150 ng mL-1 with PBS containing 0, 50, 500 or 5000 mg L-1 of 
Tween 20. Then, 200 L of diluted enzyme tracer solution were 
dispensed into the coated wells, incubated overnight at room 
temperature and washed three times with phosphate buffer 
before colorimetric detection. 
 
Evaluation of enzyme tracer binding 
Measurements were performed on microplates coated with 2 
mg mL-1 of imprinted particulate (blocking agent: PVA 1% w/v). 
The enzyme tracer was diluted to 0.1, 0.25, 0.5, 0.75, 1, 1.5 and 
2 g mL-1 with PBS containing 0.5 g L-1 of Tween 20 (PBS-Tween 
20). Then, 200 L of tracer solution were dispensed into the 
coated wells, incubated overnight at room temperature and 
washed three times with PBS before colorimetric detection. The 
apparent equilibrium dissociation constant, KD, and apparent 
binding site concentration, Bmax, were calculated by fitting the 
experimental absorbance al 450 nm, S, scaled for specific 










Molecularly imprinted sorbent assay 
Measurements  were performed in coated wells by mixing 100 
L of a cortisol solution (0, 0.25, 1.0, 2.5, 10, 25, 100, and 250 
ng mL-1 in PBS-Tween 20 and 100 L of 0.5, 0.75 or 1 g mL-1 
enzyme tracer solution in the same buffer. The microplate was 
incubated overnight at room temperature and washed three 
times with 0.05% w/v aqueous Tween 20 before colorimetric 
detection. Non-specific binding was measured by replacing the 
steroid solution with 100 L of PBS (zero ligand). Binding curves 
were fitted by means of a four parameter logistic equation:20 
 
𝐴 = 𝐴𝑠𝑎𝑡 +
𝐴0 − 𝐴𝑠𝑎𝑡






where C correspondes to cortisol concentration, A to 
absorbance value of the competition curve, Asat to absorbance 
value of solid phase saturation by cortisol, A0 to the absorbance 
value corresponding to the zero ligand condition, IC50 to the 
cortisol concentration that reduces the tracer binding to 50% 
respect to the maximum signal A0, and n to the Hill slope 
parameter. 
The limits of detection, LOD, was calculated as the cortisol 
concentration corresponding to A=A0 minus 3 standard 
deviations. The assay selectivity was evaluated by substituting 
cortisol with related steroids and using a 0.75 g mL-1 
concentration for the enzyme tracer. To allow the direct 
comparison of calibration curves related to different steroids, 
absorbance values were converted into their corresponding 









and cross-reactivity value (CR50) for each steroid was calculated 
at the inflexion point of the curve as the ratio of IC50 for cortisol 
to that of the steroid considered. 
 
Determination of cortisol in saliva 
Saliva samples were collected from healthy volunteers by 
resting an adsorbent swab inside the mouth until it was 
saturated (60–90 s). Then, the swab was placed into a 
polypropylene syringe and saliva collected by compression. 
Samples were immediately frozen and stored at -20°C. The 
molecularly imprinted sorbent assay and the confirmatory 
analyses were performed on saliva samples defrozen and 
diluted 1+1 v/v with PBS-Tween 20. 
Confirmatory analyses were carried out using a commercial 
ELISA kit (Cortisol ELISA kit − Salimetrics assay 1-3002, 
Salimetrics, CA, USA) according to manufacturer’s instructions. 
Results and discussion 
The competitive ligand binding assay studied in this paper is 
based on the binding equilibria between a variable amount of 
analyte (cortisol) and a fixed amount of enzyme tracer (cortisol-
3-CMO-HRP conjugate) for a limited amount of binding sites 
immobilised on the solid surface (cortisol-imprinted MIP). As 
previously reported, in this kind of assay the binding behaviour 
of the solid phase is of paramount relevance because it has to 
ensure a real dynamic equilibrium among all the assay 
components, allowing an efficient and balanced binding of both 
the enzyme tracer and the analyte for the polymeric binding 
sites, with the slightest non specific interaction. 
 
Coating of microtitration plates 
Among several methods described to prepare MIP-based solid 
phases, a very simple approach consists in microplates coating 
by means of imprinted microparticles.21,22 This approach has the 
advantage not to require any chemical modification of 
microwells, as the thin layer made of deposited microparticles 
can be easily stabilised by gluing it to the surface through a 
blocking agent, usually constituted by a hydrophilic polymer. As 
the assay performance greatly depends on the coating layer 
features, the amount of microparticles and the nature of the 
blocking agent used to stabilise the coating layer itself has to be 
carefully chosen, especially to limit non-specific binding. For this 
purpose, we considered six different hydrophilic polymers (PVA, 
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HPC, AG, BSA, CAS and PVP), already widely described as 
blocking agents in microplate-based immunoassays.23 PVA and 
PVP are synthetic linear polymers, HPC is a chemically-modified 
cellulose, BSA and CAS are globular proteins and AG is a complex 
mixture of glycoproteins and polysaccharides.  
In our experimental setup, two concentrations of blocking 
agents and two concentrations of NIP microparticles were 
combined to investigate their effect on non-specific binding of 
the enzyme tracer dispensed at the concentration of 50 ng mL-
1 into the coated wells. The tracer fraction bound to the coated 
surface was revealed by colorimetric detection as previously 
described. As higher absorbance values at 450 nm give the 
evidence of a stronger enzyme tracer adsorption, these 
experiments can be considered a direct measurement of non-
specific interactions on NIP-coated microplates. 
The experimental results, reported in figure 1, show that 
when the lower concentration of microparticles (i.e. 2 mg mL-1) 
is used together with the higher concentration of the blocking 
agents PVA, HPC, AG, and CAS, a significant decrease in non-
specific binding is observed. The same effect does not happen 
with BSA and PVP, whose experimental data do not reveal any 
kind of trend. Conversely, when the higher amount of 
microparticles (i.e. 20 mg mL-1) is considered, a general increase 
in non-specific binding is observed, and this effect appears to be 
more remarkable in combination with the higher concentration 
of the blocking agents (1% w/v for PVA, 4% w/v otherwise). 
Apparently, when the lower concentration of blocking agents 
(0.1% w/v for PVA, 0.4% w/v otherwise) is used, non-specific 
binding seems to be mainly dependent from the chemical 
nature of the blocking agent itself. In fact, PVA, BSA and PVP 
lead to a net decrease of it, CAS does not show appreciable 
variation, whereas HPC and GA show a net increase. 
In conclusion, for all the blocking agents considered in this 
study, when the higher concentration of blocking agent is 
coupled with the lower concentration of polymeric 
microparticles,  a limited non-specific binding is assured.      
 
Effect of surface active agents 
The non-ionic surface active agent Tween 20 has long been 
successfully used in immunoassay technology to reduce the 
non-specific binding between proteins (e.g. enzyme tracers) 
and surfaces.24-26 Likewise, in this work we aim at verifying the 
capability of this buffer additive to minimise non-specific 
binding by considering three different concentration levels: low 
(50 mg L-1), corresponding to a surface active agent 
concentration below its critical micellar concentration,27 
medium (500 mg L-1), corresponding to the typical 
concentration of Tween 20 used in conventional immunoassays, 
and high (5000 mg L-1).    
From the experimental results reported in figure 2, we 
observe that in the absence of Tween 20, adsorption of the 
enzyme tracer is proportional to its concentration, with a 
marked increase when tracer concentration is higher than 75 ng 
mL-1. The presence of Tween 20 at low level (thus, under its 
c.m.c.) does not change the adsorption pattern significantly. On 
the contrary, medium and high levels of Tween 20 (thus, beyond 
its c.m.c.) minimise non-specific binding in the considered 
experimental range of tracer concentrations. This effect is 
particularly enhanced at high enzyme tracer concentrations, 
even if it is already statistically relevant at lower values. In any 
case, no significant difference can be observed between 
Figure 1: non-specific binding of cortisol-3-CMO-HRP enzyme tracer (50 ng mL-1) to 
wells coated with 100 L of NIP microparticles suspensions. Red bars: NIP 2 mg 
mL-1, 0.4% v/v of blocking agent (0.1% v/v for PVA). Green bars: NIP 2 mg mL-1, 4% 
v/v of blocking agent (1% v/v for PVA). Yellow bars: NIP 20 mg mL-1, 0.4% v/v of 
blocking agent (0.1% v/v for PVA). Violet bars: NIP 20 mg mL-1, 4% v/v of blocking 
agent (1% v/v for PVA)
Figure 2: non-specific binding of cortisol-3-CMO-HRP enzyme tracer to wells 
coated with 100 L of NIP microparticles suspensions in the presence of Tween 20 
in the buffer. Red bars: no Tween 20. Green bars: 50 mg L-1 Tween 20. Yellow bars: 
500 mg L-1 Tween 20. Violet bars: 5000 mg L-1 Tween 20
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medium and high levels of Tween 20. So, in conclusion, a non-
ionic surface active agent as Tween 20 minimises the enzyme 
tracer non-specific binding to microparticles-coated surfaces if 
present as buffer additive at concentration over its critical 
micellar concentration. 
 
Enzyme tracer binding isotherms 
An efficient binding of the tracer to the solid phase is a key point 
for a well-performing competitive assay. As said in the 
introduction, the horseradish peroxidase used as enzyme tracer 
is a rather large biomolecule (m.w. 44000), so that binding site 
accessibility could be sterically hindered, greatly reducing the 
tracer binding. Thus, before studying any competition process 
between enzyme tracer and ligand(s), it is necessary to 
investigate that the enzyme tracer is able to bind the imprinted 
surface. From the binding curve reported in figure 3, it can be 
observed that at relatively low amount of enzyme tracer in the 
range from 0.1 to 2 g mL-1 (2.3–45 nmol L-1), a full binding 
isotherm can be obtained. Fitting by a simple langmuirian model 
and assuming an experimental value for the enzyme specific 
activity of 85 UA nmol-1, this isotherm shows an apparent 
equilibrium dissociation constant, KD, and an apparent binding 
site concentration, Bmax, of 39.7±13.5 pmol L-1  and 21.7±4.3 
nmol L-1 (0.96±0.19 g mL-1), respectively. This confirms that the 
enzyme tracer is able to bind the solid phase efficiently, 
saturating it at a concentration within the experimental range 
considered. Noticeably, this value is well below the typical 
concentration of binding sites for imprinted polymers (0.01-1 
mmol L-1),28 and this can be explained by assuming that in the 
experimental conditions of the assay, the coating protocol 
greatly reduces the accessibility of the imprinted binding sites 
by leaving only a very limited fraction available for the enzyme 
tracer. 
 
Molecularly imprinted sorbent assay 
In a competitive binding assay, the enzyme tracer should be 
able to compete efficiently with the target ligand for a limited 
amount of binding sites. Consequently, the enzyme tracer 
binding curves are expected to decrease gradually with the 
increase of the target ligand concentrations. On the basis of the 
experimental results reported in the previous section, we tested 
three different enzyme tracer concentrations close to the 
saturation value and within the range from 0.5 to 1 g mL-1. The 
resulting sigmoidal binding curves are presented in figure 4. By 
considering the logistic equation parameters reported in table 
1, the absorbance value corresponding to the absence of 
cortisol, A0, increases proportionally with the enzyme tracer 
concentration. On the other hand, the absorbance value 
corresponding to the saturation of the solid phase by cortisol, 
Asat, shows no significant differences in the presence of different 
enzyme tracer concentrations, confirming that the enzyme 
tracer and cortisol compete efficiently for the cortisol-imprinted 
binding sites.  
Table 1: logistic equation parameters for competitive ligand binding curves 
measured in the presence of  0.5, 0.75 and 1 g mL-1 of cortisol-3-CMO-HRP 
enzyme tracer. SEE: standard error estimate. LOD: limit of detection 
F-3-CMO-HRP 0.5 g mL-1 0.75 g mL-1 1 g mL-1 
A0 0.358 ± 0.008 0.593 ± 0.021 0.708 ± 0.012 
Asat 0.087 ± 0.006 0.091 ± 0.026 0.078 ± 0.012 
IC50 (ng mL-1) 1.9 ± 0.2 5.3 ± 1.2 17.5 ± 1.0 
n -1.45 ± 0.19 -1.00 ± 0.18 -1.16 ± 0.07 
 R2 0.9967 0.9914 0.9994 
SEE 







Figure 3: binding isotherm of cortisol-3-CMO-HRP enzyme tracer to wells coated 
with imprinted microparticles
Figure 4: competition curves between fixed amounts of cortisol-3-CMO-HRP 
enzyme tracer (green circles: 0.5 g mL-1; red circles: 0.75 g mL-1; violet circles: 1 
g mL-1) and variable amounts of cortisol (0.25 – 250 ng mL-1)
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To measure the selectivity towards steroids other than 
cortisol, the same competitive binding assay was performed by 
using the enzyme tracer at concentration of 0.75 g mL-1, and 
by substituting cortisol with different related steroids (i.e. 
prednisolone, prednisone, cortisone, corticosterone and 
progesterone), as reported in figure 5. The cross-reactivity 
values (CR50) (see ESI) show that the ability of the enzyme tracer 
to compete with the steroids for the imprinted binding sites 
increases with the structural diversity between steroids and 
cortisol. These experimental results confirm the selectivity 
pattern for corticosteroids measured for the same cortisol-
imprinted polymer in a previous work:11 in particular, the 
presence of the 17-COCH2OH side-chain and of hydroxy 
substituents in 11 and 17 positions fosters the competition 
of the steroidal ligand with the enzyme tracer, while the double 
bond in position 1,2 on the steroidal A-ring reduces it. It should 
be noted anyway that, independently from the confirmed 
pattern of selectivity, in the presence of the enzyme tracer the 
selectivity of the cortisol-imprinted polymer appears to be less 
marked respect to the corresponding selectivity measured by 
directly comparing the binding of different steroids. 
 
Determination of cortisol in human saliva 
To confirm the validity of the molecularly imprinted sorbent 
assay approach, human saliva samples belonging to 11 subjects 
were analysed. To evaluate the concentration of cortisol in real 
saliva samples, experimental results of three independent 
measurements were compared with those obtained using a 
confirmatory ELISA assay. As can be seen in figure 6, there is a 
good agreement between MISA and ELISA results for all the 
samples, with a full linear relationship in the range of measured 
values (2.5-20 ng mL-1) and with difference between ELISA- and 
MISA-derived values between -16% and 25% (figure 6, inset). 
That is a confirmation that the approach based on imprinted 
polymers is able to provide quantitative results comparable to 
well-estabilished ELISA. 
Conclusions 
The experimental results obtained in this work show that the 
alleged possible incompatibility between hydrophilic enzyme 
tracers and hydrophobic imprinted polymers can be 
circumvented through: i) the reduction of non-specific 
adsorption of the enzyme tracer to the imprinted polymer by 
using a non-ionic surfactant in the working buffer; ii) the choice 
of a proper type and amount of blocking agent used to fix the 
imprinted particles onto the microplate wells. In such optimised 
conditions, the enzyme tracer shows a high apparent binding 
dissociation constant and a low apparent binding site 
concentration which both agree with the good ELISA practice. 
Lastly, the settled competitive assay has proven to be suitable 
for the determination of cortisol in human saliva with sensitivity 
and selectivity in good agreement with the standard 
performance of a commercial ELISA. 
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